These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 18832192)

  • 1. Catalytically active peptidylglycine alpha-amidating monooxygenase in the media of androgen-independent prostate cancer cell lines.
    Trendel JA; Ellis N; Sarver JG; Klis WA; Dhananjeyan M; Bykowski CA; Reese MD; Erhardt PW
    J Biomol Screen; 2008 Sep; 13(8):804-9. PubMed ID: 18832192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of adrenomedullin and peptide amidation activity in human prostate cancer and in human prostate cancer cell lines.
    Rocchi P; Boudouresque F; Zamora AJ; Muracciole X; Lechevallier E; Martin PM; Ouafik L
    Cancer Res; 2001 Feb; 61(3):1196-206. PubMed ID: 11221851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen-independent expression of adrenomedullin and peptidylglycine alpha-amidating monooxygenase in human prostatic carcinoma.
    Jiménez N; Abasolo I; Jongsma J; Calvo A; Garayoa M; van der Kwast TH; van Steenbrugge GJ; Montuenga LM
    Mol Carcinog; 2003 Sep; 38(1):14-24. PubMed ID: 12949839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen deprivation of the PC-310 [correction of prohormone convertase-310] human prostate cancer model system induces neuroendocrine differentiation.
    Jongsma J; Oomen MH; Noordzij MA; Van Weerden WM; Martens GJ; van der Kwast TH; Schröder FH; van Steenbrugge GJ
    Cancer Res; 2000 Feb; 60(3):741-8. PubMed ID: 10676662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constitutive activation of the 41- and 43-kDa mitogen-activated protein (MAP) kinases in the progression of prostate cancer to an androgen-independent state.
    Oka H; Chatani Y; Kohno M; Kawakita M; Ogawa O
    Int J Urol; 2005 Oct; 12(10):899-905. PubMed ID: 16323984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ubiquitin and ubiquitin-derived peptides as substrates for peptidylglycine alpha-amidating monooxygenase.
    Chew GH; Galloway LC; McIntyre NR; Schroder LA; Richards KM; Miller SA; Wright DW; Merkler DJ
    FEBS Lett; 2005 Aug; 579(21):4678-84. PubMed ID: 16098968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and functional expression of human pancreatic peptidylglycine alpha-amidating monooxygenase.
    Tateishi K; Arakawa F; Misumi Y; Treston AM; Vos M; Matsuoka Y
    Biochem Biophys Res Commun; 1994 Nov; 205(1):282-90. PubMed ID: 7999037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of the transformed phenotype and inhibition of peptidylglycine alpha-monooxygenase in Ras-transformed cells by 4-phenyl-3-butenoic acid.
    Sunman JA; Foster MS; Folse SL; May SW; Matesic DF
    Mol Carcinog; 2004 Dec; 41(4):231-46. PubMed ID: 15468302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and processing of peptidylglycine alpha-amidating monooxygenase messenger RNA in rat prostate.
    Samos LF; Gkonos PJ
    Prostate; 1996 Aug; 29(2):101-6. PubMed ID: 8700799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oleic acid derived metabolites in mouse neuroblastoma N18TG2 cells.
    Merkler DJ; Chew GH; Gee AJ; Merkler KA; Sorondo JP; Johnson ME
    Biochemistry; 2004 Oct; 43(39):12667-74. PubMed ID: 15449956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical characterization of peptide alpha-amidation enzyme activities of human neuroendocrine lung cancer cell lines.
    Treston AM; Scott FM; Vos M; Iwai N; Mains RE; Eipper BA; Cuttitta F; Mulshine JL
    Cell Growth Differ; 1993 Nov; 4(11):911-20. PubMed ID: 8297797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of prohormone processing enzymes in neuroendocrine and non-neuroendocrine cells.
    Eipper BA; Green CB; Mains RE
    J Natl Cancer Inst Monogr; 1992; (13):163-8. PubMed ID: 1389689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptidylglycine alpha-amidating monooxygenase- and proadrenomedullin-derived peptide-associated neuroendocrine differentiation are induced by androgen deprivation in the neoplastic prostate.
    Jiménez N; Jongsma J; Calvo A; van der Kwast TH; Treston AM; Cuttitta F; Schröder FH; Montuenga LM; van Steenbrugge GJ
    Int J Cancer; 2001 Oct; 94(1):28-34. PubMed ID: 11668475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thiorphan, tiopronin, and related analogs as substrates and inhibitors of peptidylglycine alpha-amidating monooxygenase (PAM).
    McIntyre NR; Lowe EW; Chew GH; Owen TC; Merkler DJ
    FEBS Lett; 2006 Jan; 580(2):521-32. PubMed ID: 16405966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells.
    Tso CL; McBride WH; Sun J; Patel B; Tsui KH; Paik SH; Gitlitz B; Caliliw R; van Ophoven A; Wu L; deKernion J; Belldegrun A
    Cancer J; 2000; 6(4):220-33. PubMed ID: 11038142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion of peptide amidation enzymatic activity leads to edema and embryonic lethality in the mouse.
    Czyzyk TA; Ning Y; Hsu MS; Peng B; Mains RE; Eipper BA; Pintar JE
    Dev Biol; 2005 Nov; 287(2):301-13. PubMed ID: 16225857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Embryonic and uterine expression patterns of peptidylglycine alpha-amidating monooxygenase transcripts suggest a widespread role for amidated peptides in development.
    Zhang J; Zheng M; Eipper BA; Pintar JE
    Dev Biol; 1997 Dec; 192(2):375-91. PubMed ID: 9441675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide alpha-amidation and peptidylglycine alpha-hydroxylating monooxygenase: control by disulfiram.
    Mueller GP; Husten EJ; Mains RE; Eipper BA
    Mol Pharmacol; 1993 Nov; 44(5):972-80. PubMed ID: 8246921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptidyl-glycine alpha-amidating monooxygenase targeting and shaping of atrial secretory vesicles: inhibition by mutated N-terminal ProANP and PBA.
    Labrador V; Brun C; König S; Roatti A; Baertschi AJ
    Circ Res; 2004 Dec; 95(12):e98-109. PubMed ID: 15539631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The peptidylglycine alpha-amidating monooxygenase (PAM): a novel prodrug strategy for amidoximes and N-hydroxyguanidines?
    Schade D; Kotthaus J; Hungeling H; Kotthaus J; Clement B
    ChemMedChem; 2009 Oct; 4(10):1595-9. PubMed ID: 19693765
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.